Synanthrin segmentation by type distinguishes three principal categories: synthetic Synanthrin, natural Synanthrin, and hybrid Synanthrin. Synthetic Synanthrin, produced through controlled chemical pathways, dominates the market with an estimated 58 % of total revenue, driven by its consistent purity and scalability for bulk applications. Natural Synanthrin, extracted from botanical sources, accounts for roughly 27 % of sales; its niche appeal lies in regulatory environments that favor bio‑derived inputs, particularly within the pharmaceutical and nutraceutical sectors. Hybrid Synanthrin combines synthetic backbones with natural side‑chains, representing the remaining 15 % of the market. This segment is expanding as manufacturers seek to balance performance attributes with sustainability claims, especially in high‑value formulations where cost sensitivity is lower. Collectively, these type sub‑segments define the structural foundation of the Synanthrin market, influencing supply chain configurations, pricing dynamics, and R&D investment priorities. Projected growth rates suggest that synthetic Synanthrin will maintain its lead, while hybrid offerings could achieve a compound annual growth rate of 9 % through 2030, reflecting increasing demand for eco‑balanced compounds.